DLGAP1-AS3

Across TCGA pan-cancer cohorts, DLGAP1-AS3 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated DLGAP1-AS3 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher DLGAP1-AS3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated DLGAP1-AS3 expression acts as an unfavorable survival marker, although some lineages such as OV and THCA show a favorable association.

KIRC, COAD, and LUSC are the cancer types where DLGAP1-AS3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.537	0.720	<.001	69	view →
COAD	OS	Tertile	IV	0.293	0.681	.001	54	view →
LUSC	DFS	Quartile	All	0.515	0.779	<.001	43	view →
KIRP	OS	Median	II,III,IV	0.632	0.880	.005	42	view →
BRCA	OS	Tertile	IV	0.341	0.882	<.001	36	view →
ACC	DFS	Tertile	III,IV	0.161	0.527	.001	27	view →
OV	OS	Median	All	0.734	0.650	.010	26	view →
THCA	DFS	Tertile	III,IV	1.000	0.858	.002	23	view →
MESO	DFS	Median	II,III,IV	0.506	0.315	.019	18	view →
BLCA	DFS	Tertile	IV	0.275	0.529	.012	14	view →
CHOL	DFS	Quartile	All	0.277	1.000	.013	9	view →
THYM	DFS	Quartile	II,III,IV	0.713	0.883	.039	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

DLGAP1-AS3–KIRC (OS)

Open the KIRC breakdown →